Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02347488 · ClinicalTrials.gov registry record · Phase 4

Endotracheal Tube Holder and Bite Guard Research

A Phase 4 study of Surgery and Anesthesia, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 4
Development phase
30
Enrollment target
1
Study location

NCT02347488: Completed Phase 4 study of Surgery and Anesthesia, sponsored by University of California, Los Angeles.

NCT02347488 is a Phase 4 study of Surgery and Anesthesia that has completed, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02347488, a Phase 4 study of Surgery and Anesthesia, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 4
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the effectiveness of a novel combined endotracheal tube holder and bite guard when compared with the current standard of care, tape and an oral airway.

Primary Outcome

The ability of the securing device to resist endotracheal tube dislodgement under axial strain for patients in the supine position was measured. The endotracheal tube, once secured with either tape or the Haider airway device, encountered an axial force to simulate the endotracheal tube being pulled from the mouth. The force increased over approximately 5 seconds until the target of 15 N was reached or until the principal investigator deemed that the force be aborted to prevent possible tracheal

Conditions Studied

Interventions

  • DEVICE Haider ETT Tube Holder and Bite Guard
  • PROCEDURE Tape

Study Locations (1)

California

  • University of California - Los Angeles

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-02
Est. Completion 2016-01
Phase Phase 4

What the finished NCT02347488 record still lists

NCT02347488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Haider ETT Tube Holder and Bite Guard is the first listed.

NCT02347488 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02347488 about?

NCT02347488 is a clinical study titled "Endotracheal Tube Holder and Bite Guard Research". This study aims to test the effectiveness of a novel combined endotracheal tube holder and bite guard when compared with the current standard of care, tape and an oral airway.

What is the current status of trial NCT02347488?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2015-02. Estimated completion is 2016-01.

What conditions does trial NCT02347488 study?

This clinical trial studies the following conditions: Surgery, Anesthesia.

What interventions are being tested in trial NCT02347488?

The interventions under investigation include: Haider ETT Tube Holder and Bite Guard (DEVICE), Tape (PROCEDURE).

Who is sponsoring clinical trial NCT02347488?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02347488 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02347488's enrollment target sits among peer trials

30 107th of 120 higher than 9 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02347488, the US trial registry maintained by the National Library of Medicine. NCT02347488 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.